Matinas BioPharma Holdings, Inc.
MTNB
$0.18
$0.00-0.87%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -6.69M | -10.61M | -10.35M | -16.87M | -19.61M |
| Total Depreciation and Amortization | 284.00K | 402.00K | 456.00K | 608.00K | 741.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 771.00K | 4.48M | 4.39M | 8.45M | 9.16M |
| Change in Net Operating Assets | -784.00K | -877.00K | -1.51M | -1.20M | -1.33M |
| Cash from Operations | -6.42M | -6.61M | -7.01M | -9.01M | -11.04M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | 335.00K | 335.00K | 335.00K | 320.00K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 500.00K | 10.15M |
| Cash from Investing | 335.00K | 335.00K | 335.00K | 820.00K | 10.15M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -8.00K | -8.00K | -9.00K | -3.00K | -5.00K |
| Issuance of Common Stock | 129.00K | 129.00K | 129.00K | 64.00K | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -65.00K |
| Issuance of Preferred Stock | 0.00 | 1.65M | 3.30M | 3.30M | 3.30M |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -27.00K | -29.00K | -29.00K | -29.00K |
| Cash from Financing | 121.00K | 1.74M | 3.39M | 3.33M | 3.20M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.96M | -4.53M | -3.29M | -4.86M | 2.31M |